Scarica l'app Stockscreener
4.66
1.75%
0.08
Pre-mercato:
4.56
-0.10
-2.15%
Precedente Chiudi:
$4.58
Aprire:
$4.68
Volume 24 ore:
318.18K
Relative Volume:
0.54
Capitalizzazione di mercato:
$1.45B
Reddito:
$391.87M
Utile/perdita netta:
$-441.45M
Rapporto P/E:
-2.5189
EPS:
-1.85
Flusso di cassa netto:
$-301.21M
1 W Prestazione:
-9.16%
1M Prestazione:
-14.81%
6M Prestazione:
-48.34%
1 anno Prestazione:
-64.43%
Intervallo 1D:
$4.57
$4.77
Intervallo di 1 settimana:
$4.40
$5.14
Portata 52W:
$4.32
$13.70
Alvotech Stock (ALVO) Company Profile
Confronta ALVO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
4.66 | 1.43B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
125.67 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.90 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.05 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.40 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
52.88 | 16.33B | 0 | -5.87M | -767.30K | -0.45 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Underweight |
| 2025-11-04 | Downgrade | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-02-14 | Iniziato | UBS | Buy |
| 2024-01-29 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-09-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-07 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-09-06 | Downgrade | Citigroup | Buy → Sell |
| 2022-07-26 | Iniziato | Citigroup | Buy |
Mostra tutto
Alvotech Borsa (ALVO) Ultime notizie
Alvotech Corrects Disclosure on December 2025 Insider-Related Share Transactions - TipRanks
Correction: Transactions of Managers and Closely Associated Persons - The Manila Times
ATP Holdings ehf. Reports Share Transactions in Alvotech to CSSF - Quiver Quantitative
Alvotech fixes error in report on 4.8M-share buy and later sale of stock - Stock Titan
Why retail investors favor Alvotech stockMarket Profile Overview & Discover Your Financial Freedom Formula - ulpravda.ru
Is Alvotech stock near bottom after declineStraddle and Strangle Trades & Rapid Capital Growth - bollywoodhelpline.com
The Truth About Alvotech: Is This ‘Generic Giant’ Stock Your Next Power Move? - AD HOC NEWS
Alvotech Reports Major Insider-Related Share Purchases Filed in Luxembourg - TipRanks
Alvotech intros Simponi biosimilar in Europe - Drug Store News
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Transactions of Managers and Closely Associated Persons - The Manila Times
Viðskipti stjórnenda og tengdra aðila - GlobeNewswire Inc.
Alvotech (NASDAQ:ALVO) Shares Down 5.5%Time to Sell? - MarketBeat
Alvotech Founder Róbert Wessman to Hand CEO Role to Lisa Graver in Planned Q1 2026 Succession - TipRanks
Startup Alvotech secures €100 mn term loan to fund 2026 execution - Beinsure
Alvotech names Lisa Graver as new CEO as founder steps back - Investing.com
Alvotech names Lisa Graver as new CEO as founder steps back By Investing.com - Investing.com Canada
Alvotech CEO Robert Wessman to step down, Lisa Graver to succeed - TipRanks
Alvotech Announces Leadership Transition: Róbert Wessman Remains Executive Chairman, Lisa Graver Appointed CEO - Quiver Quantitative
Alvotech announces planned CEO succession and leadership transition - The Manila Times
Alvotech Announces CEO Changes - MarketScreener
Alvotech (ALVO) Stock Analysis: Unveiling A Striking 352% Potential Upside - DirectorsTalk Interviews
Alvotech Secures $100 Million Term Loan Facility Led By GoldenTree - Pulse 2.0
Alvotech (NASDAQ:ALVO) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP - FinancialContent
A Look At Alvotech (ALVO) Valuation After New US$100 Million Term Loan To Fund Biosimilar Pipeline - simplywall.st
Alvotech raises USD 100 million term loan to bolster biosimilar growth and 2026 launches - MSN
Icelandic biotech Alvotech secures to supercharge biosimilars pipeline and supply chain - Tech Funding News
Alvotech : Managers’ transactionsMTN ATP 19.12EN - MarketScreener
Alvotech : Managers' transactionsALVOTECH - MarketScreener
Alvotech (NasdaqGM:ALVO) Valuation Check After New $100 Million GoldenTree Term Loan for Biosimilar Growth - Yahoo Finance
The Truth About Alvotech: Why Everyone on Wall Street Suddenly Cares - AD HOC NEWS
Alvotech Stock Analysis and ForecastInstitutional Buying Trends & Free Superior Profit Margins - earlytimes.in
Alvotech secures USD 100M term loan - Medical Buyer
ROSEN, LEADING INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - ACCESS Newswire
Alvotech Raises USD 100 Million Term Loan to Bolster Biosimilar Growth and 2026 Launches - TipRanks
Alvotech’s Volatile Ascent: Can A High?Beta Biosimilar Pure Play Keep Its Momentum? - AD HOC NEWS
Alvotech secures $100 million loan facility - Biostock
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment - EU-Startups
What analysts say about Alvotech Z45 stockEarnings Forecast Updates & Double Digit Returns - earlytimes.in
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in US - MSN
Alvotech Secures USD 100 Million Senior Term Loan to Enhance Liquidity and Support R&D Initiatives - Quiver Quantitative
Alvotech Secures Term Loan Facility of USD 100 Million - The Manila Times
Alvotech (NASDAQ:ALVO) Trading 2.9% HigherShould You Buy? - MarketBeat
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - PR Newswire
Alvotech announced that it has received $100 million in funding - marketscreener.com
The Technical Signals Behind (ALVO) That Institutions Follow - Stock Traders Daily
Alvotech Files Notification with CSSF Regarding Changes in Own Shares - Quiver Quantitative
Changes in company's own shares - marketscreener.com
Alvotech : Changes in company's own shares - marketscreener.com
Alvotech Azioni (ALVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.03%
2.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):